CS logo
small CS logo
Privatklinik Dr. R. Schindlbeck GmbH & Co. KG

Herrsching Am Ammersee, Germany
Hospital in Herrsching, Bavaria
Seestraße 43, 82211 Herrsching am Ammersee

About Privatklinik Dr. R. Schindlbeck GmbH & Co. KG


"Spezialklinik für Innere Medizin seit 1946. Wir zeichnen uns durch eine einzigartige Kombination aus modernsten medizinischen Methoden und einer patientenorientierten Behandlungsphilosophie aus. „Im Mittelpunkt unserer Bemühungen steht der kranke Mensch“, so brachte es Dr. Robert Schindlbeck auf den Punkt. Im Laufe des Bestehens wurde die Klinik durch ihre erstklassigen diagnostischen Einrichtungen und die Behandlungserfolge bis weit über die Grenzen Bayerns bekannt. Ob gesetzlich oder privat versichert bei uns sind alle Patienten herzlich willkommen. Unser Ziel ist es, Ihnen medizinische Versorgung aus einer Hand auf höchstem Niveau und in freundlicher Umgebung anbieten zu können."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
German CLL Study Group
3
Hoffmann-La Roche
1
Total Rows: 3

Clinical Trials at Privatklinik Dr. R. Schindlbeck GmbH & Co. KG


During the past decade, Privatklinik Dr. R. Schindlbeck GmbH & Co. KG conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman High-GradeNon-Hodgkin'sLymphoma StudyGroup: 4German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 4German CLL Study Group: 3German CLL Study Group: 3Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsGerman CLL Study Group: 1German CLL Study Group: 1

Clinical Trials Conditions at Privatklinik Dr. R. Schindlbeck GmbH & Co. KG


According to Clinical.Site data, the most researched conditions in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" are "Lymphoma" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" in a lesser frequency.

Clinical Trials Intervention Types at Privatklinik Dr. R. Schindlbeck GmbH & Co. KG


Most popular intervention types in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" are "Drug" (8 trials), "Biological" (4 trials), "Radiation" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Privatklinik Dr. R. Schindlbeck GmbH & Co. KG


The vast majority of trials in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" are 8 trials for "All" genders.

Clinical Trials Status at Privatklinik Dr. R. Schindlbeck GmbH & Co. KG


Currently, there are NaN active trials in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Privatklinik Dr. R. Schindlbeck GmbH & Co. KG, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Privatklinik Dr. R. Schindlbeck GmbH & Co. KG, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8